The Association between Metabolic Syndrome and Morbid Events in Type 2 Diabetes after a 7-Year Community Management: Beijing Community Diabetes Study 17
Table 1
Baseline clinical characteristics in different groups.
Variable
Non-MS group
MS group
()
()
Age (year)
0.336
Gender ( (%))
Male
473 (57.89)
942 (34.79)
<0.001
Female
344 (42.11)
1766 (65.21)
Educational attainment ( (%))
<0.001
Illiteracy or elementary school
102 (12.52)
522 (19.44)
Middle school
511 (62.70)
1616 (60.19)
College or academic degree
202 (24.79)
547 (20.37)
Diabetic duration (year)
4.0 (0.3, 9.3)
3.8 (0.0, 9.1)
0.227
Body mass index (kg/m2)
<0.001
Waist circumference (cm)
<0.001
Neck circumference (cm)
<0.001
Systolic blood pressure (mmHg)
<0.001
Diastolic blood pressure (mmHg)
<0.001
Fasting plasma glucose (mmol/l)
0.009
Postprandial glucose (mmol/l)
0.011
Hemoglobin A1c (%)
<0.001
Hemoglobin A1c (mmol/mol)
<0.001
Triglyceride (mmol/l)
<0.001
Total cholesterol (mmol/l)
0.03
High-density lipoprotein cholesterol (mmol/l)
<0.001
Low-density lipoprotein cholesterol (mmol/l)
0.049
Uric acid (μmol/l)
260 (209, 324)
289 (232, 348)
<0.001
Urinary albumin excretion rate (μg/min)
6.6 (4.5, 12.2)
8.3 (5.2, 19.0)
<0.001
Smoking ( (%))
139 (17.01)
403 (14.88)
0.139
Antihypertension medication ( (%))
316 (38.68)
1836 (67.80)
<0.001
Antihyperglycemic medication ( (%))
753 (92.17)
2475 (91.40)
0.487
Metformin ( (%))
247 (30.23)
694 (25.63)
0.009
Sulfonylurea ( (%))
327 (40.02)
1270 (46.90)
0.001
Insulin ( (%))
166 (20.32)
595 (21.97)
0.314
Statin ( (%))
126 (15.42)
607 (22.42)
<0.001
Values are expressed as , numbers (%), or median (range). Diabetic duration, uric acid, and urinary albumin excretion rate: median (range); the nonparametric test was used. MS: metabolic syndrome.
